EUVIMEDEUVIMED entdecken
Open Access

Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States

Cameron B Haas iD, Meredith S Shiels, Ruth M Pfeiffer, Monica D'Arcy, Qianlai Luo, Kelly Yu, April A Austin, Colby Cohen, Paige Miller, Bozena M Morawski, Karen Pawlish, William T Robinson und 1 weitere

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Cameron B Haas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Immunocompromised Host, Neoplasms, HIV Infections, Organ Transplantation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NCHHSTP CDC HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunosuppressed individuals have elevated risk of virus-related cancers. Identifying cancers with elevated risk in people with HIV and solid organ transplant recipients, 2 immunosuppressed populations, may help identify novel etiologic relationships with infectious agents.

Methods

We used 2 linkages of population-based cancer registries with HIV and transplant registries in the United States. Cancer entities were systematically classified according to site and histology codes. Standardized incidence ratios were used to compare risk in people with HIV and solid organ transplant recipients with the general population. For selected cancer entities, incidence rate ratios were calculated for indicators of immunosuppression within each population.

Results

We identified 38 047 cancer cases in solid organ transplant recipients and 53 592 in people with HIV, yielding overall standardized incidence ratios of 1.66 (95% confidence interval [CI] = 1.65 to 1.68) and 1.49 (95% CI = 1.47 to 1.50), respectively. A total of 43 cancer entities met selection criteria, including conjunctival squamous cell carcinoma (people with HIV standardized incidence ratio = 7.1, 95% CI = 5.5 to 9.2; solid organ transplant recipients standardized incidence ratio = 9.4, 95% CI = 6.8 to 12.6). Sebaceous adenocarcinoma was elevated in solid organ transplant recipients (standardized incidence ratio = 16.2, 95% CI = 14.0 to 18.6) and, among solid organ transplant recipients, associated with greater risk in lung and heart transplant recipients compared with recipients of other organs (incidence rate ratio = 2.3, 95% CI = 1.7 to 3.2). Salivary gland tumors, malignant fibrous histiocytoma, and intrahepatic cholangiocarcinoma showed elevated risk in solid organ transplant recipients (standardized incidence ratio = 3.9, 4.7, and 3.2, respectively) but not in people with HIV. However, risks for these cancers were elevated following an AIDS diagnosis among people with HIV (incidence rate ratio = 2.4, 4.3, and 2.0, respectively).

Conclusions

Elevated standardized incidence ratios among solid organ transplant recipients and people with HIV, and associations with immunosuppression within these populations, suggest novel infectious causes for several cancers including conjunctival squamous cell carcinoma, sebaceous adenocarcinoma, salivary gland tumors, malignant fibrous histiocytoma, and intrahepatic cholangiocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostNeoplasmsHIV InfectionsOrgan TransplantationHumansUnited StatesMaleFemaleIncidenceMiddle AgedAdultRegistriesAgedCarcinoma, Squamous CellTransplant RecipientsRisk Factors

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • New York State Cancer Registry, Albany, NY, USA.
  • Florida Department of Health, Tallahassee, FL, USA.
  • Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, TX, USA.
  • Cancer Data Registry of Idaho, Boise, ID, USA.
  • New Jersey Department of Health, Trenton, NJ, USA.

ORCID-Profile: Cameron B Haas

Förderung

  • NIEHS NIH HHS
  • NCHHSTP CDC HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NCCDPHP CDC HHS
  • NLM NIH HHS
  • ORFDO NIH HHS

Zitieren

APA

Haas, C. B., Shiels, M. S., Pfeiffer, R. M., D'Arcy, M., Luo, Q., Yu, K., Austin, A. A., Cohen, C., Miller, P., Morawski, B. M., Pawlish, K., Robinson, W. T., & Engels, E. A. (2024). Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae159

Vancouver

Haas CB, Shiels MS, Pfeiffer RM, D'Arcy M, Luo Q, Yu K, et al. Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae159

BibTeX
@article{Haas2024,
  author = {Haas, Cameron B and Shiels, Meredith S and Pfeiffer, Ruth M and D'Arcy, Monica and Luo, Qianlai and Yu, Kelly and Austin, April A and Cohen, Colby and Miller, Paige and Morawski, Bozena M and Pawlish, Karen and Robinson, William T and Engels, Eric A},
  title = {Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae159}
}
Kostenlos starten →